Home > Items where lead contributor is European Monitoring Centre for Drugs and Drug Addiction

Up a level
Export as
Group by: Item Type | No Grouping
Number of items: 270.

Article

European Monitoring Centre for Drugs and Drug Addiction. (2009) Neurobiological research on drugs: ethical and policy implications. Drugs in Focus , 19 , pp. 1-4.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Responding to drug driving in Europe. Drugs in Focus , (20) .

News

[European Monitoring Centre for Drugs and Drug Addiction] Council adopts conclusions on alternatives to coercive sanctions for drug using offenders. (08 Mar 2018)

[European Monitoring Centre for Drugs and Drug Addiction] MDMB-CHMICA to be placed under control across the EU. (27 Feb 2017)

[European Monitoring Centre for Drugs and Drug Addiction] Dangerous synthetic drugs hit the EU market. (05 Mar 2014)

[European Monitoring Centre for Drugs and Drug Addiction] EU drugs agency announces Scientific Committee line-up for next three years. (20 Dec 2013)

European Monitoring Centre for Drugs and Drug Addiction. EMCDDA welcomes European Commission call for stronger EU action on new drugs. (17 Sep 2013)

European Monitoring Centre for Drugs and Drug Addiction. New drug 4-MA to be placed under control across the EU. (07 Mar 2013)

European Monitoring Centre for Drugs and Drug Addiction. Leading experts to review global developments in new drugs and ‘legal highs’. (07 Jun 2012)

European Monitoring Centre for Drugs and Drug Addiction. Early warning system - national profile. (25 May 2012)

European Monitoring Centre for Drugs and Drug Addiction. EMCDDA launches first European quality standards to improve drug prevention in the EU. (09 Dec 2011)

[European Monitoring Centre for Drugs and Drug Addiction] Towards a stronger European response to drugs. (26 Oct 2011)

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] EMCDDA to acknowledge excellence in scientific writing. (04 Mar 2011)

[European Monitoring Centre for Drugs and Drug Addiction] ‘Drug problems have no age limits’ — more older drug users seeking help, says EMCDDA. (10 Nov 2010)

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Europe faces new challenges posed by changes in drug supply and use. (10 Nov 2010)

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Over 1 million drug users a year in treatment, but considerable challenges remain. (10 Nov 2010)

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Drug use and pregnancy: challenges for public health. (01 Jul 2010)

[European Monitoring Centre for Drugs and Drug Addiction] EMCDDA–EUROPOL Annual report reviews new drugs entering the market. Record number of new drugs reported in 2009, says report. (23 Apr 2010)

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Harm reduction moves to the mainstream: EU drugs agency publishes major work on harm reduction: past, present and future. (23 Apr 2010)

[European Monitoring Centre for Drugs and Drug Addiction] New drug BZP to be placed under control across the EU. (04 Mar 2008)

Report

European Monitoring Centre for Drugs and Drug Addiction. (2019) Ireland country drug report 2019. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2018) European drug report 2018 trends and developments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Ireland, country drug report 2018. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol 2016 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland, country drug report 2017. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2017) European drug report 2017 trends and developments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Cannabis legislation in Europe: an overview. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA Programming document 2017–19. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug supply reduction: an overview of EU policies and measures. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug trafficking penalties across the European Union: a survey of expert opinion. Technical report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA strategy 2025. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Lisbon: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) EMCDDA–Europol Joint report on a new psychoactive substance: methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) General report of activities 2015 — Key achievements and governance: a year in review. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) European drug report 2016: trends and developments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Recent changes in Europe’s MDMA/ecstasy market. EMCDDA rapid communication. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) EMCDDA Strategy and work programme 2016–18: annual work programme 2016. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Alternatives to punishment for drug-using offenders. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2015) EMCDDA-Europol 2014 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2015) European drug report 2015: trends and developments. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2015) New psychoactive substances in Europe. An update from the EU Early Warning System March 2015. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Internal statistics code of practice. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Report on the risk assessment of 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) in the framework of the Council Decision on new psychoactive substances. Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Report on the risk assessment of 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-dimethylaminorex, 4,4′-DMAR) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Financing drug policy in Europe in the wake of the economic recession. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA-Europol 2013 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 4,4′-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine. Luxembourg: Joint Reports, Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2014) EMCDDA–Europol 2013 annual report on the implementation of Council Decision 2005/387/JHA. Brussels: EMCDDA; Europol.

European Monitoring Centre for Drugs and Drug Addiction. (2014) European drug report 2014: trends and developments. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA. Work programme 2014. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Estimating public expenditure on drug-law offenders in prison in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Exploring methamphetamine trends in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Multidimensional family therapy for adolescent drug users: a systematic review. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Drug use, impaired driving and traffic accidents. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) General report of activities 2013: Key achievements and governance: a year in review. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Pregnancy and opioid use: strategies for treatment, EMCDDA Papers. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Residential treatment for drug use in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2013) European drug report 2013: trends and developments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Drug prevention interventions targeting minority ethnic populations: issues raised by 33 case studies. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Drug policy profiles — Ireland. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2013) EU drug markets report: a strategic analysis. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2013) EMCDDA–Europol 2012 Annual report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2013) EMCDDA–Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole. Luxembourg: EMCDDA–Europol.

European Monitoring Centre for Drugs and Drug Addiction. (2013) General report of activities 2012. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2013) North American drug prevention programmes: are they feasible in European cultures and contexts? Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Work programme 2013. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) 2012 Annual report on the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Prevalence of daily cannabis use in the European Union and Norway. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Pregnancy, childcare and the family: key issues for Europe’s response to drugs. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA 2013–15 strategy and work programme. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Travel and drug use in Europe: a short review. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Treatment demand indicator (TDI) standard protocol 3.0: Guidelines for reporting data on people entering drug treatment in European countries. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Drug demand reduction: global evidence for local actions. Drugs in Focus 23. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Responding to drug use and related problems in recreational settings. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2011. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Drug-related research in Europe: recent developments and future perspectives. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Work programme 2012. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Cannabis production and markets in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) A definition of ‘drug mules’ for use in a European context. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA final annual accounts 2011. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA trend report for the evaluation of the 2005–12 EU drugs strategy. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2012) EMCDDA–Europol 2011 annual report on the implementation of Council Decision 2005/387/JHA. Lisbon: EMCDDA; Europol.

European Monitoring Centre for Drugs and Drug Addiction, European Centre for Disease Prevention and Control. (2012) Joint EMCDDA and ECDC rapid risk assessment. HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; European Centre for Disease Prevention and Control.

European Monitoring Centre for Drugs and Drug Addiction. (2012) The Reitox network: frequently asked questions. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2011) Amphetamine: a European Union perspective in the global context. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Responding to new psychoactive substances. Drugs in Focus 22. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Annual report 2011: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Cost and financing of drug treatment services in Europe. Luxembourg: Publications Offi ce of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) EMCDDA: Work programme 2011. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2010. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Khat use in Europe: implications for European policy. Luxembourg: Office for Offical Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Mortality related to drug use in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Online sales of new psychoactive substances/'legal highs': summary of results from the 2011 multilingual snapshots. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Pilot study on wholesale drug prices in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2010) EMCDDA 2010 selected issue: trends in injecting drug use in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2009. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2010) EMCDDA–Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Harm reduction: evidence, impacts and challenges. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Risk assessment of new psychoactive substances — operating guidelines. Luxembourg: The Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Annual report 2010: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2010) Cocaine: A European Union perspective in the global context. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, European Commission. (2010) The European Union and the drug phenomenon: frequently asked questions. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Problem amphetamine and methamphetamine use in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Treatment and care for older drug users. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) EMCDDA conference proceedings: identifying Europe's information needs for effective drug policy. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Annual report 2009: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Drug offences: sentencing and other outcomes. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) EMCDDA 2009 Thematic paper: Understanding the 'Spice' phenomenon. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Polydrug use: patterns and responses. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Summary: The 2007 ESPAD report. Substance use among students in 35 countries. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Thematic paper: Women’s voices: experiences and perceptions of women facing drug problems. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2008. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Preventing later substance use disorders in at-risk children and adolescents. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) EMCDDA 2008 selected issue - Drugs and vulnerable groups of young people. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) EMCDDA 2008 selected issue - National drug-related research in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) EMCDDA 2008 selected issue - Towards a better understanding of drug-related public expenditure in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual report 2008: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2007. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) GHB and its precursor GBL: an emerging trend case study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2008) Monitoring the supply of cocaine to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2008) Monitoring the supply of heroin to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2008) Sexual assaults facilitated by drugs or alcohol. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2008) Thematic paper on indicated prevention. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) EMCDDA 2007 selected issue - cocaine and crack cocaine: a growing public health issue. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) EMCDDA 2007 selected issue - Drug use and related problems among very young people (under 15 years old). Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) EMCDDA 2007 selected issue - Drugs and driving. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual report 2007: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2006. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) Treatment of problem cocaine use: a review of the literature. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2005: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2006: selected issues. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual Report 2006: The state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2005. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) Hallucinogenic mushrooms. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2006) Monitoring new drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2005) Differences in patterns of drug use between women and men. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2005) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2005: selected issues. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2005) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2004. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2005) Illicit drug use in the EU: legislative approaches. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2005) Youth media. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2004) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2004 Annual report: the state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2004) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2003. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2004) Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2004) Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2003) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2003: the state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2003) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2002. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2003) European Monitoring Centre for Drugs and Drug Addiction annual report 2003: the state of the drugs problem in the acceding and candidate countries to the European Union. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Annual report on the state of the dugs problem in the European Union and Norway 2002. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Early-warning system on new synthetic drugs: guidance on implementation. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2002) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2001. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Report on the drug situation in the candidate CEECs 2002. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2001) Annual report on the state of the drugs problem in the European Union 2001. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2001) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2000. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2000) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report on the state of the drugs problem in the European Union 2000. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2000) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1999. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1998. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Extended annual report on the state of the drugs problem in the European Union 1999. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Guidelines for the risk assessment of new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Literature review on the relation between drug use, impaired driving and traffic accidents. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Scientific review of the literature on estimating the prevalence of drug misuse on the local level. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (1998) Annual report on the state of the drugs problem in the European Union 1998. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1998) Annual report on the state of the drugs problem in the European Union 1998: summary and highlights. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1998) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1997. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (1998) Guidelines for the evaluation of drug prevention: a manual for programme planners and evaluators. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1997) Annual report on the state of the drugs problem in the European Union 1997. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1997) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1996. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, European University Institute. (1997) Joint seminar. Drugs: research initiatives in the European Union: synthesis report. Florence: EMCDDA; European University Institute.

European Monitoring Centre for Drugs and Drug Addiction. (1997) Literature review of studies of mortaility and feasibility study for a common methodology. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (1996) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1995. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (1995) Annual report on the state of the drugs problem in the European Union 1995. Luxembourg: Office for Official Publications of the European Communities.

Evidence resource

European Monitoring Centre for Drugs and Drug Addiction. (2019) Take-home naloxone. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2019) European drug report 2019: trends and developments. Luxembourg: Publications Office of the European Union. 98 p.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Drugs in syringes from six European cities: results from the ESCAPE project 2017. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Penalties for drug law offences in Europe at a glance. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2019) An analysis of post-mortem toxicology practices in drug-related death cases in Europe. Luxembourg: Publications Office of the European Union. 52 p.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Drug prevention: exploring a systems perspective. Technical report. Luxembourg: Publications Office of the European Union. 41 p.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Wastewater analysis and drugs — a European multi-city study. European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2018) m-Health applications for responding to drug use and associated harms. Luxembourg: Publications Office of the European Union. 20 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Trendspotter manual: a handbook for the rapid assessment of emerging drug-related trends. Luxembourg: Publications Office of the European Union. 60 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Perspectives on drugs: preventing overdose deaths in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union. 58 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union. 58 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) EMCDDA–Europol 2017 annual report on the implementation of Council Decision 2005/387/JHA, implementation reports. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union. 64 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4-fluoroisobutyrylfentanyl 4F-iBF), in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union. 55 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances. Risk assessments. Luxembourg: Publications Office of the European Union. 50 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Drug consumption rooms: an overview of provision and evidence (Perspectives on drugs). Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 8 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) New psychoactive substances in prison. Luxembourg: Publications Office of the European Union. 20 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Drug-related homicide in Europe: a first review of the data and literature, EMCDDA Papers. Luxembourg: Publications Office of the European Union. 53 p.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) Report on the risk assessment of N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 83 p. 10.2810/716236 I ISBN 978-92-9497-245-3

European Monitoring Centre for Drugs and Drug Addiction. (2018) Wastewater analysis and drugs — a European multi-city study (Perspectives on drugs). Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 10 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) The misuse of benzodiazepines among high-risk opioid users in Europe (perspectives on drugs). Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 10 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Recent changes in Europe’s cocaine market: results from an EMCDDA trendspotter study. Luxembourg: Publications Office of the European Union. 28 p.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction. 67 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug squads: units specialised in drug law enforcement in Europe. Luxembourg: Publications Office of the European Union. 14 p.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2017) Drugs and the darknet: perspectives for enforcement, research and policy. Luxembourg: Publications Office of the European Union. 90 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol joint report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl) amino]piperidine-4-carboxylate (carfentanil). Luxembourg: Publications Office of the European Union. 19 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug treatment expenditure: a methodological overview, EMCDDA Insights 24. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Health and social responses to drug problems: a European guide. Luxembourg: Publications Office of the European Union. 188 p.

[European Monitoring Centre for Drugs and Drug Addiction] (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA). Luxembourg: Joint Reports, Publications Office of the European Union. 15 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB). Luxembourg: Joint Reports, Publications Office of the European Union. 16 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Luxembourg: Joint Reports, Publications Office of the European Union. 15 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Luxembourg: Joint Reports, Publications Office of the European Union. 14 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide (tetrahydrofuranylfentanyl; THF-F). Luxembourg: Joint Reports, Publications Office of the European Union. 13 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: changes in Europe’s cannabis resin market. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: Synthetic cannabinoids in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: Wastewater analysis and drugs — a European multi-city study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) European Facility Survey Questionnaire (EFSQ) package. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) High-risk drug use and new psychoactive substances. Luxembourg: Publications Office of the European Union. 24 p. EMCDDA Rapid Communication

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: Drug consumption rooms: an overview of provision and evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 8 p.

European Monitoring Centre for Drugs and Drug Addiction. (2016) How can contingency management support treatment for substance use disorders? A systematic review. Luxembourg: Publications Office of the European Union. 46 p.

European Monitoring Centre for Drugs and Drug Addiction. (2016) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-l]acetamide (acetylfentanyl),. Luxembourg: Publications Office of the European Union. 21 p. Joint reports

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: changes in Europe’s cannabis resin market. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: cocaine trafficking to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

(2016) Perspectives on drugs: comorbidity of substance use and mental health disorders in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: strategies to prevent diversion of opioid substitution treatment medications. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

European Monitoring Centre for Drugs and Drug Addiction. (2016) The internet and drug markets. Luxembourg: Publications Office of the European Union. 136 p. EMCDDA Insights 21

European Monitoring Centre for Drugs and Drug Addiction. (2016) Emergency department-based brief interventions for individuals with substance-related problems: a review of effectiveness. Luxembourg: Publications Office of the European Union. 20 p.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Characteristics of frequent cannabis users with and without dependence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone. Luxembourg: Publications Office of the European Union. 37 p. EMCDDA Papers

European Monitoring Centre for Drugs and Drug Addiction. (2015) Final report of the European drug emergencies network (Euro‐DEN) March 2015. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA best practice portal: prevention interventions for partygoers.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Drug-related infectious diseases. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) EMCDDA manuals no 7. European drug prevention quality standards. A manual for prevention professionals. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Final report: demand reduction networking in Austria, Ireland, the Netherlands, Spain and Sweden. Stockholm: National Institute of Public Health. 24 p.

Book

European Monitoring Centre for Drugs and Drug Addiction. (2010) First European conference on drug supply indicators — key conclusions. Lisbon: European Monitoring Centre for Drugs and Drug Addiction .

European Monitoring Centre for Drugs and Drug Addiction. (2009) Addiction neurobiology: ethical and social implications. EMCDDA Scientific Monograph Series; No. 9 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2008) Assessing illicit drugs in wastewater. EMCDDA Insights Series no. 9. Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2008) A cannabis reader: global issues and local experiences. EMCDDA Scientific Monograph Series; No. 8 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2008) Drug use, impaired driving and traffic accidents. EMCDDA Insights Series no. 8. Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2008) Prevention of substance abuse. EMCDDA Insights Series no. 7 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2002) Prosecution of drug users in Europe: varying pathways to similar objectives. EMCDDA Insight Series Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2000) Reviewing current practice in drug-substitution treatment in the European Union. EMCDDA Insights Series no. 3 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (1999) Evaluating the treatment of drug abuse in the European Union. EMCDDA Scientific Monograph Series; No. 3 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (1998) Evaluating drug prevention in the European Union. EMCDDA Scientific Monograph Series; No. 2 Luxembourg: Office for Official Publications of the European Communities .

Newsletter

European Monitoring Centre for Drugs and Drug Addiction. (2016) Drugnet Europe 94. April–June . Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Drugnet Europe. 88 , (October–December) . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Drugnet Europe. 77 . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Drugnet Europe 75. July–September . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Drugnet Europe 74. April–June . Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Drugnet Europe 73. January - March . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Drugnet Europe 72. October–December . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Conference or Workshop Item

European Monitoring Centre for Drugs and Drug Addiction. (2015) EMCDDA general population survey presentations. In: General population surveys annual expert meeting, 17–18 June 2015, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Presentations from the Lisbon addictions conference 2015. In: EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs, 21-22 September, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction, European Centre for Disease Prevention and Control. (2014) EMCDDA and ECDC sub-regional exchange of knowledge and best practice in monitoring and preventing drug-related infections. In: Meeting reports, November 2013, Bucharest and Talinn.

European Monitoring Centre for Drugs and Drug Addiction. (2013) European exchange on Brief Interventions and Motivational Interviewing for people using drugs. In: European exchange meeting, 23 January 2013, Lisbon.

Video

European Monitoring Centre for Drugs and Drug Addiction. (2016) The Internet and drug markets. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Women and drug use in Europe.

Other

European Monitoring Centre for Drugs and Drug Addiction. (2016) Prevention profiles. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Statistical bulletin 2011. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. (2010) EMCDDA statistical bulletin 2010. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

FactSheet

European Monitoring Centre for Drugs and Drug Addiction. (2015) Best practice in drug interventions: prescription medicines. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Factsheet from the EU drugs agency in Lisbon: responding to the drugs driving in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

This list was generated on Fri Sep 20 03:09:30 2019 GMT.